Cryptotanshinone Suppresses Androgen Receptor-mediated Growth in Androgen Dependent and Castration Resistant Prostate Cancer Cells

Androgen receptor (AR) is the major therapeutic target for the treatment of prostate cancer (PCa). Anti-androgens to reduce or prevent androgens binding to AR are widely used to suppress AR-mediated PCa growth; however, the androgen depletion therapy is only effective for a period of time. Here we f...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Xu, Defeng, Lin, Tzu-Hua, Li, Shaoshun, Da, Jun, Wen, Xing-Qiao, Ding, Jiang, Chang, Chawnshang, Yeh, Shuyuan
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3283034/
https://ncbi.nlm.nih.gov/pubmed/22154085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2011.10.006
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares